COVID-19 Vaccine Front-Runner to Enter Final Stage as Positive Results Get Published

0 2

ScienceAlert– “The US biotech firm Moderna said Tuesday it would enter the final stage of human trials for its COVID-19 vaccine on July 27, after promising early results were published in an influential journal.”
“The Phase 3 trial will recruit 30,000 participants in the US, with half to receive the vaccine at 100 microgram dose levels, and the other half to receive a placebo.”
“It is designed to show whether the vaccine is safe and can prevent infection by the SARS-CoV-2 virus, or – if people still get infected – whether it can prevent the infection from progressing toward symptoms.”
“If they do get symptoms, the vaccine can still be considered a success if it stops severe cases of COVID-19.”

You might also like
Leave A Reply

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More